ESR1 and breast carcinoma: Next, we determined the expression level of miR-575 in ER+ (≥75%) and ER- (<1%) breast cancer specimens by RT-qPCR, and the results showed that miR-575 expression was significantly higher in ER+ breast cancer specimens (Figure 1D).